abbvie glp-1 receptor agonist weight management diabetes treatments What's New in Obesity Treatment? Clinical Management of Weight Regain

The absence of regional guidelines underscores an urgent need for context-specific recommendations

[DOI] [PubMed] [Google Scholar] 552.Fang Y., Jiang D., Wang Y., Wang Q., Lv D., Liu J

[DOI] [PubMed] [Google Scholar] 642.Yu M., Moreno C., Hoagland K.M., Dahly A., Ditter K., Mistry M

This is the phase where most people who are going to notice cardiovascular changes will notice them

[86] found that semaglutide, as a GLP-1 analog, can directly act on fat cells, increase the expression of thermogenic genes for browning phenotype maintenance, improve the expression of UCP1, mitochondrial biosynthesis and thermogenic marker, thereby contributing to weight loss